P797: Costs distribution of conventional or biologic drugs in ulcerative colitis and Crohn’s disease: A single outpatient centre experienceECCO '18 Vienna
2018
P798: The experience of inflammatory bowel disease patients with health care in Spain: Insights from the IEXPAC projectECCO '18 Vienna
2018
P799: Frequency of vaccination for herpes zoster (HZ) among inflammatory bowel disease (IBD) patientsECCO '18 Vienna
2018
P800: Five-year prospective follow-up of paediatric IBD patients based on HUPIR (Hungarian paediatric IBD registry)ECCO '18 Vienna
2018
P801: Trends in inflammatory bowel disease incidence in Korea: A nationwide population-based study 2004–2015ECCO '18 Vienna
2018
P802: The experience of chronic disease patients with health care can influence adherence to medication. IEXPAC ProjectECCO '18 Vienna
2018
P803: Non-immunity against hepatitis B virus in patients with newly diagnosed inflammatory bowel diseaseECCO '18 Vienna
2018
P805: Adherence to Mediterranean diet is associated with decreased faecal calprotectin in patients after pouch surgeryECCO '18 Vienna
2018
P807: Patients’ perceptions on faecal microbiota transfer in inflammatory bowel diseaseECCO '18 Vienna
2018
P808: The prevalence and risk factors of non-alcoholic fatty liver disease in inflammatory bowel diseasesECCO '18 Vienna
2018
P809: Disease severity in patients with inflammatory bowel disease associated with cardiovascular diseasesECCO '18 Vienna
2018
P810: Serious pulmonary infections in patients with inflammatory bowel disease on treatment with anti-TNFECCO '18 Vienna
2018
P811: Centre volume bias for restorative surgery after ulcerative colitis colectomy in England and SwedenECCO '18 Vienna
2018
P812: Natural disease course of inflammatory bowel disease unclassified in a prospective European population-based inception cohort—the Epi-IBD cohortECCO '18 Vienna
2018
P813: Occurrence, disease course and prognosis of perianal Crohn’s disease in a Danish population-based inception cohort—a 10-year follow-up studyECCO '18 Vienna
2018
P814: Latent cytomegalovirus infection does not influence disease course in inflammatory bowel diseaseECCO '18 Vienna
2018